Aptamer Market

Aptamers are high affinity molecules that are derived from RNA or DNA. These are normally generated using a synthetic process called ?Systematic evolution of ligands by exponential enrichment? (SELEX).
Aptamers receive their name from the Latin word aptus meaning ?fit?. This means they bind to the target molecules with high specificity and high affinity.
Aptamers are short nucleic acids that interact with a variety of targets with high affinity and specificity. They have been shown to inhibit biological functions of cognate target proteins, and they are identifiable by an in vitro selection process, also termed SELEX (Systematic Evolution of Ligands by EXponential enrichment). Being nucleic acids, aptamers can be synthesized chemically or enzymatically.
Aptamer Market aims to provide a comprehensive presentation of the global market for Aptamer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aptamer. Aptamer Market contains market size and forecasts of Aptamer in global, including the following market information:
Global Aptamer Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Aptamer market was valued at US$ 252.3 million in 2022 and is projected to reach US$ 812.5 million by 2030, at a CAGR of 18.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Aptamers key players include TriLink BioTechnologies, SomaLogic, AM Biotechnologies, Aptamer Sciences, Base Pair Biotechnologies etc. The Global top 10 manufacturers hold a share about 14%.North America is the largest market, with a share about 45%, followed by Europe and Asia Pacific with the share about 30% and 22%.
We surveyed the Aptamer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Aptamer Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Aptamer Market Segment Percentages, by Type, 2022 (%)
DNA-Based Aptamers
RNA-Based Aptamers
Global Aptamer Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Aptamer Market Segment Percentages, by Application, 2022 (%)
Research and Development
Drug Discovery
Global Aptamer Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Aptamer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Aptamer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Aptamer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
TriLink BioTechnologies
AptaBharat
SomaLogic
AM Biotechnologies
Aptamer Sciences
Base Pair Biotechnologies
Aptamer Group
Aptagen
Aptus Biotech
NeoVentures Biotechnology
Ray Biotech
Vivonics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Aptamer, market overview.
Chapter 2: Global Aptamer market size in revenue.
Chapter 3: Detailed analysis of Aptamer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Aptamer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.